Strongyloidiasis risk factors: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[ | Common risk factors in the development of strongyloidiasis include [[immunosuppressive therapies]] with [[corticosteroids]] and other medications, [[HTLV-1 infection]], [[organ transplantation]], [[immune reconstitution syndrome]], hematologic malignancies (especially [[lymphoma]]), [[tuberculosis]], and [[malnutrition]] | ||
==Risk factors== | ==Risk factors== | ||
Revision as of 15:48, 9 August 2017
|
Strongyloidiasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Strongyloidiasis risk factors On the Web |
|
American Roentgen Ray Society Images of Strongyloidiasis risk factors |
|
Risk calculators and risk factors for Strongyloidiasis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Common risk factors in the development of strongyloidiasis include immunosuppressive therapies with corticosteroids and other medications, HTLV-1 infection, organ transplantation, immune reconstitution syndrome, hematologic malignancies (especially lymphoma), tuberculosis, and malnutrition
Risk factors
Strongyloides is found more frequently among the socioeconomically disadvantaged and institutionalized populations and in rural areas.Risk factors and predisposing conditions include: [1][2]
- Walking with bare feet
- Occupations that increase contact with contaminated soil such as farming and coal mining
- human T-cell lymphotropic virus-1 (HTLV-1) infection
- Immunosuppressive therapies with corticosteroids and other medications,
- Immune reconstitution syndrome
- Hematologic malignancies (lymphoma)
- Tuberculosis
- Malnutrition
References
- ↑ Evering T, Weiss LM (2006). "The immunology of parasite infections in immunocompromised hosts". Parasite Immunol. 28 (11): 549–65. doi:10.1111/j.1365-3024.2006.00886.x. PMC 3109637. PMID 17042927.
- ↑ Ostera G, Blum J (2016). "Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States". Curr Trop Med Rep. 3: 1–3. doi:10.1007/s40475-016-0065-3. PMC 4757600. PMID 26925367.